Michael CW - Search Results

1

Cadherin expression in ovarian carcinoma and malignant mesothelioma cell effusions.

Sivertsen S, Berner A, Michael CW, Bedrossian C, Davidson B. Sivertsen S, et al. Among authors: michael cw. Acta Cytol. 2006 Nov-Dec;50(6):603-7. doi: 10.1159/000326027. Acta Cytol. 2006. PMID: 17152269

2

Intraoperative consultation in ovarian lesions: a comparison between cytology and frozen section.

Michael CW, Lawrence WD, Bedrossian CW. Michael CW, et al. Diagn Cytopathol. 1996 Dec;15(5):387-94. doi: 10.1002/(SICI)1097-0339(199612)15:5<387::AID-DC6>3.0.CO;2-9. Diagn Cytopathol. 1996. PMID: 8989540

3

Immunocytochemistry of serous effusion specimens: a comparison of ThinPrep vs cell block.

Gong Y, Sun X, Michael CW, Attal S, Williamson BA, Bedrossian CW. Gong Y, et al. Among authors: michael cw. Diagn Cytopathol. 2003 Jan;28(1):1-5. doi: 10.1002/dc.10219. Diagn Cytopathol. 2003. PMID: 12508174

4

Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.

Afify AM, Stern R, Michael CW. Afify AM, et al. Among authors: michael cw. Diagn Cytopathol. 2005 Mar;32(3):145-50. doi: 10.1002/dc.20201. Diagn Cytopathol. 2005. PMID: 15690337

5

The expression pattern of beta-catenin in mesothelial proliferative lesions and its diagnostic utilities.

Dai Y, Bedrossian CW, Michael CW. Dai Y, et al. Among authors: michael cw. Diagn Cytopathol. 2005 Nov;33(5):320-4. doi: 10.1002/dc.20281. Diagn Cytopathol. 2005. PMID: 16240396 Free article.

6

The role of immunohistochemistry in distinguishing squamous cell carcinoma from mesothelioma and adenocarcinoma in pleural effusion.

Li Q, Bavikatty N, Michael CW. Li Q, et al. Among authors: michael cw. Semin Diagn Pathol. 2006 Feb;23(1):15-9. doi: 10.1053/j.semdp.2006.06.007. Semin Diagn Pathol. 2006. PMID: 17044191

7

Immunohistochemical expression and distribution of VEGFR-3 in malignant mesothelioma.

Filho AL, Baltazar F, Bedrossian C, Michael C, Schmitt FC. Filho AL, et al. Diagn Cytopathol. 2007 Dec;35(12):786-91. doi: 10.1002/dc.20767. Diagn Cytopathol. 2007. PMID: 18008346 Free article.

8

Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions.

Pu RT, Pang Y, Michael CW. Pu RT, et al. Among authors: michael cw. Diagn Cytopathol. 2008 Jan;36(1):20-5. doi: 10.1002/dc.20747. Diagn Cytopathol. 2008. PMID: 18064689 Free article.

9

Podoplanin is a useful marker for identifying mesothelioma in malignant effusions.

Hanna A, Pang Y, Bedrossian CW, Dejmek A, Michael CW. Hanna A, et al. Among authors: michael cw. Diagn Cytopathol. 2010 Apr;38(4):264-9. doi: 10.1002/dc.21340. Diagn Cytopathol. 2010. PMID: 20146302 Free article.

10

The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions.

Hasteh F, Lin GY, Weidner N, Michael CW. Hasteh F, et al. Among authors: michael cw. Cancer Cytopathol. 2010 Apr 25;118(2):90-6. doi: 10.1002/cncy.20071. Cancer Cytopathol. 2010. PMID: 20209622 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters